Navigation Links
Beaumont holds first international congress on underactive bladder

Underactive bladder, estimated to affect more than 20 percent of the elderly population, is an unrecognized disease that has a major influence on the health and independence of seniors.

Beaumont Health System urologists hope to heighten awareness of underactive bladder, or UAB, through an international forum funded in part by the National Institutes of Health. The Feb. 20-21 Congress of Urologic Research and Education on Aging Underactive Bladder, orCURE-UAB, in Bethesda, Md., is attracting physicians, researchers and nurses from around the world for scientific discussion and interdisciplinary collaboration.

Underactive bladder syndrome is a chronic, complex and debilitating disease affecting a person's ability to empty their bladder. Those with an underactive bladder can hold unusually large amounts of urine but have a diminished sense of when the bladder is full and are not able to contract the muscles sufficiently or forcefully enough to empty the bladder.

Symptoms and severity of the condition can vary. Some with UAB must use a strawcatheter several times a day to empty their bladder. This puts them at risk of developing catheter-associated infections. Others have indwelling catheters, left in place for a period of time, or undergo surgical procedures to relieve UAB symptoms.

UAB is primarily associated with aging, diabetes, and neurological diseases, and itis a major cause of nursing home admissions. Currently, no medications or therapies have proven effective in the long-term treatment of UAB and no known cure exists. UAB can also lead to other conditions such as urinary tract infections, bladder stones, or, in severe cases, kidney damage. The emotional effects of the disease can be devastating‒causing embarrassment, and diminishing both quality of life and independence.

"CURE-UAB is the first meeting dedicated to discussion of underactive bladder and features a world-renowned faculty," says Michael Chancellor, M.D., director, neuro-urology, Beaumont Health System. "Our goal is to bring the world's top clinicians and researchers together to collaborate and promote advancement of underactive bladder research and education"

Physicians and researchers from as far away as Australia, Japan, and India are expected to attend.

At the forum, Beaumont researchers will present the results of the first population-based research of underactive bladder syndrome. Twenty-three percent of the 633 respondents in Metro Detroit reported having a problem emptying the bladder completely, yet only 11 percent had ever heard of UAB. Those reporting UAB symptoms were twice as likely to describe their health as "poor" or "fair" compared to other respondents. The results suggest that the burden and impact of UAB are significant.

Dr. Chancellor will discuss novel therapies for treating UAB, including stem cell and gene therapy. The world's first stem cell treatment for UAB was performed at Beaumont last September.


Contact: Angela Blazevski
Beaumont Health System

Related medicine news :

1. Beaumont Health System first outside of Japan to test new atrial fibrillation technology
2. Beaumont Health System Research: Accelerated Breast Radiation Treatment Provides Same Outcomes after 10 Years
3. Victory Medical Center Beaumont Celebrates 1000th Surgery
4. Beaumont, Royal Oak repeats as Consumer Choice Award winner for 18th time
5. Beaumont Health System Launches Research Trial of Bioresorbable Heart Scaffold
6. Beaumont Health System launches research trial of bioresorbable heart scaffold
7. Beaumont Study: Nerve Stimulation Helps with Overactive Bladder
8. Beaumont Health System Recognized as an American Heart Association Fit-Friendly Worksite
9. Beaumont Cardiologist Kavitha Chinnaiyan, M.D., Receives Excellence in Research Award
10. Beaumont cardiologist Kavitha Chinnaiyan, M.D., receives excellence in research award
11. Beaumont receives national green award
Post Your Comments:
(Date:11/25/2015)... ... November 25, 2015 , ... “While riding the bus, I ... Bronx, N.Y. “I thought there had to be a convenient and comfortable way to ... The PROTECTOR enables disabled individuals to safely travel during cold or inclement weather. In ...
(Date:11/25/2015)... , ... November 25, 2015 , ... ... (PHA) announces the nation’s Periwinkle Pioneers, individuals and groups responsible for advancing care ... disease. The Periwinkle Pioneers, nominated by the public, will receive special recognition throughout ...
(Date:11/25/2015)... ... November 25, 2015 , ... ... philanthropic seniors, is resulting in a way for homeless people to have a ... have launched a new initiative whereby they are repurposing plastic bags into sleeping ...
(Date:11/25/2015)... ... November 25, 2015 , ... Since its launch in 2012, ... adult stem cell therapies to patients with chronic degenerative medical conditions. Now, the ... Registered Trademark (RTM). , Organizations are required to hold a registered trademark in ...
(Date:11/24/2015)... ... November 25, 2015 , ... Genesis Chiropractic Software ... software creates an agreement between the practice owner and the patient that automatically ... notification, and projections. Click here to learn more. , ...
Breaking Medicine News(10 mins):
(Date:11/24/2015)... FRANCISCO , Nov. 24, 2015  Thanks to ... Dignity Health St. Mary,s Medical Center,s Sister Diane Grassilli ... breast imaging capabilities in San Francisco ... an anonymous friend, stepped forward with a gift of ... for Breast Digital Mammography with Tomosynthesis and Whole Breast ...
(Date:11/24/2015)... Colo. , Nov. 24, 2015  Array ... that its Chief Executive Officer, Ron Squarer ... Healthcare Conference in New York.  The public is ... webcast on the Array BioPharma website.Event:Piper Jaffray Annual ... , Wednesday, December 2, 2015Time:1:30 p.m. Eastern Time ...
(Date:11/24/2015)... HOUSTON, TX and VANCOUVER, Nov. 24, 2015 /PRNewswire/ ... EPI; NASDAQ: EPIX ) announced today that the ... clinical study of EPI-506 as a treatment for metastatic ... States and Canada.  --> ... --> In the Phase 1/2 clinical trial, ...
Breaking Medicine Technology: